Health-related quality of life (HRQoL) in advanced endometrial cancer (aEC) patients (pts) treated with lenvatinib plus pembrolizumab or treatment of physician's choice (TPC) Meeting Abstract
| Authors: | Lorusso, D.; Colombo, N.; Herraez, A. C.; Santin, A.; Colomba, E.; Miller, D. S.; Fujiwara, K.; Pignata, S.; Baron-Hay, S. E.; Ray-Coquard, I. L.; Shapira-Frommer, R.; Kim, Y. M.; McCormack, M.; Bird, S.; Prabhu, V. S.; Nguyen, A. M.; Zhao, Q.; Dutta, L.; Makker, V. |
| Abstract Title: | Health-related quality of life (HRQoL) in advanced endometrial cancer (aEC) patients (pts) treated with lenvatinib plus pembrolizumab or treatment of physician's choice (TPC) |
| Meeting Title: | 2021 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2021 Jun 4-8 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-05-20 |
| Language: | English |
| ACCESSION: | WOS:000708120603171 |
| DOI: | 10.1200/JCO.2021.39.15_suppl.5570 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 5570 -- Source: Wos |
